<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01315340</url>
  </required_header>
  <id_info>
    <org_study_id>8068</org_study_id>
    <nct_id>NCT01315340</nct_id>
  </id_info>
  <brief_title>Ocular Rigidity and Outflow Facility in Glaucomatous and Normal Eyes</brief_title>
  <official_title>Measurement of Ocular Rigidity, Outflow Facility and Ocular Blood Flow in Glaucomatous and Normal Eyes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Larissa University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Crete</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Larissa University Hospital</source>
  <brief_summary>
    <textblock>
      Ocular rigidity characterizes the relationship between pressure and volume changes in the&#xD;
      human eye and is expressed as a macroscopic coefficient. Outflow facility is a measure of the&#xD;
      resistance of the conventional outflow pathway and represents a parameter that is of interest&#xD;
      in glaucoma.&#xD;
&#xD;
      Difficulties in the measurement of ocular rigidity in the living human eye have limited our&#xD;
      knowledge on this parameter. However, ocular biomechanics have been implicated in the&#xD;
      pathogenesis of this disease. The aim of this study is to characterize the pressure volume&#xD;
      relation and quantify ocular rigidity and outflow facility in glaucomatous and normal eyes.&#xD;
      For this purpose, the investigators have recently developed a manometric method for the&#xD;
      measurement of ocular rigidity and outflow facility.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular rigidity coefficient</measure>
    <time_frame>2 minutes measurement of ocular rigidity</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Outflow facility coefficient</measure>
    <time_frame>3-4 minutes measurement of outflow facility</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ocular pulse amplitude</measure>
    <time_frame>6 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulsatile ocular blood flow</measure>
    <time_frame>6 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Glaucoma Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ocular rigidity, outflow facility and intraocular pressure measurement</intervention_name>
    <description>The measurement procedure includes cannulation of the anterior chamber of the eye, under sterile conditions. Infusion of the eye with microvolumes of a saline solution is performed, followed by manometric measurement of intraocular pressure, in order to quantify ocular rigidity. Outflow facility is estimated from recordings of intraocular pressure after the infusion is stopped.</description>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_label>Glaucoma Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with primary open or pseudoexfoliation glaucoma that are undergoing cataract&#xD;
             surgery&#xD;
&#xD;
          -  Patients undergoing cataract surgery without evidence of other ocular disease.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Evidence of any ocular disease, other than specified in the inclusion criteria&#xD;
&#xD;
          -  Previous ophthalmic surgery or trauma&#xD;
&#xD;
          -  Significant visual field defect (MD&lt;-12dB) or an increased cup to disc ratio (&gt;0.9).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ioannis Pallikaris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Crete</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ioannis Pallikaris, MD</last_name>
    <phone>2810392351</phone>
    <phone_ext>+30</phone_ext>
    <email>ioanpall@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ophthalmology Department, University Hospital of Larissa</name>
      <address>
        <city>Larissa</city>
        <zip>41110</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Dastiridou, MD</last_name>
      <email>anna.dastiridou@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Anna Dastiridou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Dastiridou AI, Ginis HS, De Brouwere D, Tsilimbaris MK, Pallikaris IG. Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of intraocular pressure. Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5718-22. doi: 10.1167/iovs.09-3760. Epub 2009 Jul 15.</citation>
    <PMID>19608534</PMID>
  </reference>
  <reference>
    <citation>Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA, Christodoulakis E, Tsilimbaris MK. Ocular rigidity in patients with age-related macular degeneration. Am J Ophthalmol. 2006 Apr;141(4):611-5.</citation>
    <PMID>16564793</PMID>
  </reference>
  <reference>
    <citation>Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA, Tsilimbaris MK. Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):409-14.</citation>
    <PMID>15671262</PMID>
  </reference>
  <reference>
    <citation>Dastiridou AI, Ginis H, Tsilimbaris M, Karyotakis N, Detorakis E, Siganos C, Cholevas P, Tsironi EE, Pallikaris IG. Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of axial length. Invest Ophthalmol Vis Sci. 2013 Mar 1;54(3):2087-92. doi: 10.1167/iovs.12-11576.</citation>
    <PMID>23462745</PMID>
  </reference>
  <reference>
    <citation>Dastiridou AI, Tsironi EE, Tsilimbaris MK, Ginis H, Karyotakis N, Cholevas P, Androudi S, Pallikaris IG. Ocular rigidity, outflow facility, ocular pulse amplitude, and pulsatile ocular blood flow in open-angle glaucoma: a manometric study. Invest Ophthalmol Vis Sci. 2013 Jul 10;54(7):4571-7. doi: 10.1167/iovs.13-12303.</citation>
    <PMID>23761082</PMID>
  </reference>
  <reference>
    <citation>Karyotakis NG, Ginis HS, Dastiridou AI, Tsilimbaris MK, Pallikaris IG. Manometric measurement of the outflow facility in the living human eye and its dependence on intraocular pressure. Acta Ophthalmol. 2015 Aug;93(5):e343-8. doi: 10.1111/aos.12652. Epub 2015 Feb 1.</citation>
    <PMID>25645503</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 9, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2011</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Larissa University Hospital</investigator_affiliation>
    <investigator_full_name>Anna Dastiridou</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

